Commodore Capital
North America, New York, United States, New York
Description
Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
Investor Profile
Commodore Capital has made 33 investments, with 5 in the past 12 months and 12% as lead.
Stage Focus
- Post Ipo Equity (70%)
- Series B (12%)
- Series C (3%)
- Seed (3%)
- Undisclosed (3%)
- Series A (3%)
- Series Unknown (3%)
- Private Equity (3%)
Country Focus
- United States (88%)
- United Kingdom (3%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (3%)
- France (3%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Health Diagnostics
- Clinical Trials
- Biopharma
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
